Allin DM - Search Results

1

In vitro hydrodynamic properties of the Miethke ProGAV hydrocephalus shunt.

Allin DM, Czosnyka ZH, Czosnyka M, Richards HK, Pickard JD. Allin DM, et al. Cerebrospinal Fluid Res. 2006 Jun 29;3:9. doi: 10.1186/1743-8454-3-9. Cerebrospinal Fluid Res. 2006. PMID: 16808836 Free PMC article.

2

Laboratory study on "intracranial hypotension" created by pumping the chamber of a hydrocephalus shunt.

Bromby A, Czosnyka Z, Allin D, Richards HK, Pickard JD, Czosnyka M. Bromby A, et al. Cerebrospinal Fluid Res. 2007 Mar 26;4:2. doi: 10.1186/1743-8454-4-2. Cerebrospinal Fluid Res. 2007. PMID: 17386089 Free PMC article.

3

Investigation of the hydrodynamic properties of a new MRI-resistant programmable hydrocephalus shunt.

Allin DM, Czosnyka M, Richards HK, Pickard JD, Czosnyka ZH. Allin DM, et al. Cerebrospinal Fluid Res. 2008 Apr 21;5:8. doi: 10.1186/1743-8454-5-8. Cerebrospinal Fluid Res. 2008. PMID: 18426562 Free PMC article.

4

In vivo assessment of hydrocephalus shunt.

Petrella G, Czosnyka M, Smielewski P, Allin D, Guazzo EP, Pickard JD, Czosnyka ZH. Petrella G, et al. Acta Neurol Scand. 2009 Nov;120(5):317-23. doi: 10.1111/j.1600-0404.2009.01176.x. Epub 2009 May 20. Acta Neurol Scand. 2009. PMID: 19456302

5

Laboratory testing of the Pressio intracranial pressure monitor.

Allin D, Czosnyka M, Czosnyka Z. Allin D, et al. Neurosurgery. 2008 May;62(5):1158-61; discussion 1161. doi: 10.1227/01.neu.0000325878.67752.eb. Neurosurgery. 2008. PMID: 18580814

6

Circulating tumour DNA is a potential biomarker for disease progression and response to targeted therapy in advanced thyroid cancer.

Allin DM, Shaikh R, Carter P, Thway K, Sharabiani MTA, Gonzales-de-Castro D, O'Leary B, Garcia-Murillas I, Bhide S, Hubank M, Harrington K, Kim D, Newbold K. Allin DM, et al. Eur J Cancer. 2018 Nov;103:165-175. doi: 10.1016/j.ejca.2018.08.013. Epub 2018 Sep 22. Eur J Cancer. 2018. PMID: 30253333

7

Multi-analyte profiling in human carotid atherosclerosis uncovers pro-inflammatory macrophage programming in plaques.

Shalhoub J, Viiri LE, Cross AJ, Gregan SM, Allin DM, Astola N, Franklin IJ, Davies AH, Monaco C. Shalhoub J, et al. Among authors: allin dm. Thromb Haemost. 2016 May 2;115(5):1064-72. doi: 10.1160/TH15-08-0650. Epub 2016 Jan 14. Thromb Haemost. 2016. PMID: 26763091 Free article.

8

Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the Collaborative Atorvastatin Diabetes Study (CARDS).

Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, Charlton-Menys V, DeMicco DA, Fuller JH; CARDS Investigators. Colhoun HM, et al. Am J Kidney Dis. 2009 Nov;54(5):810-9. doi: 10.1053/j.ajkd.2009.03.022. Epub 2009 Jun 21. Am J Kidney Dis. 2009. PMID: 19540640 Clinical Trial.

9

Pharmacist-acquired medication histories in a university hospital emergency department.

Carter MK, Allin DM, Scott LA, Grauer D. Carter MK, et al. Among authors: allin dm. Am J Health Syst Pharm. 2006 Dec 15;63(24):2500-3. doi: 10.2146/ajhp060028. Am J Health Syst Pharm. 2006. PMID: 17158698

10

Gatifloxacin 400 mg as a single shot or 200 mg once daily for 3 days is as effective as ciprofloxacin 250 mg twice daily for the treatment of patients with uncomplicated urinary tract infections.

Naber KG, Allin DM, Clarysse L, Haworth DA, James IG, Raini C, Schneider H, Wall A, Weitz P, Hopkins G, Ankel-Fuchs D. Naber KG, et al. Among authors: allin dm. Int J Antimicrob Agents. 2004 Jun;23(6):596-605. doi: 10.1016/j.ijantimicag.2003.12.017. Int J Antimicrob Agents. 2004. PMID: 15194131 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13 results

Search Page